Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6.

Ogasawara S, Fujii Y, Kaneko MK, Oki H, Sabit H, Nakada M, Suzuki H, Ichimura K, Komori T, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2016 Oct;35(5):254-258.

2.

Structural basis for multi-specific peptide recognition by the anti-IDH1/2 monoclonal antibody, MsMab-1.

Kitago Y, Kaneko MK, Ogasawara S, Kato Y, Takagi J.

Biochem Biophys Res Commun. 2016 Sep 23;478(3):1274-9. doi: 10.1016/j.bbrc.2016.08.110. Epub 2016 Aug 20.

PMID:
27553275
3.

A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.

Liu X, Ogasawara S, Kaneko MK, Oki H, Hozumi Y, Goto K, Takagi M, Kato Y.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):636-42. doi: 10.1016/j.bbrc.2015.02.162. Epub 2015 Mar 6.

PMID:
25753205
4.

Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas.

Takano S, Kato Y, Yamamoto T, Liu X, Ishikawa E, Kaneko MK, Ogasawara S, Matsuda M, Noguchi M, Matsumura A.

Brain Tumor Pathol. 2015 Jul;32(3):169-75. doi: 10.1007/s10014-015-0214-8. Epub 2015 Feb 5.

PMID:
25652153
5.

Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.

Kato Y.

Brain Tumor Pathol. 2015 Jan;32(1):3-11. doi: 10.1007/s10014-014-0202-4. Epub 2014 Oct 17. Review.

PMID:
25324168
6.

Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone.

Kato Kaneko M, Liu X, Oki H, Ogasawara S, Nakamura T, Saidoh N, Tsujimoto Y, Matsuyama Y, Uruno A, Sugawara M, Tsuchiya T, Yamakawa M, Yamamoto M, Takagi M, Kato Y.

Cancer Sci. 2014 Jun;105(6):744-8. doi: 10.1111/cas.12413.

7.

Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1.

Liu X, Kato Y, Kaneko MK, Sugawara M, Ogasawara S, Tsujimoto Y, Naganuma Y, Yamakawa M, Tsuchiya T, Takagi M.

Cancer Med. 2013 Dec;2(6):803-14. doi: 10.1002/cam4.149. Epub 2013 Oct 17.

8.

Monoclonal antibody MsMab-1 against mutated IDH1 and IDH2.

[No authors listed]

Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):429. doi: 10.1089/mab.2013.0056. No abstract available.

PMID:
24328750
9.

Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations.

Ogasawara S, Kaneko MK, Tsujimoto Y, Liu X, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):377-81. doi: 10.1089/mab.2013.0050.

PMID:
24328739
10.

Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.

Kato Kaneko M, Ogasawara S, Kato Y.

Tohoku J Exp Med. 2013 Jun;230(2):103-9.

Supplemental Content

Loading ...
Support Center